Post-market surveillanceNeuropeptide
Compound 61491
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061491
Risk Class
MODERATE
Last Audit
Mar 6, 2108
Research Abstract
Neuropeptide candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61491 is a neuropeptide asset inside neuropeptide innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in post-market surveillance with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061491 with updates logged 2108-03-06.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61491Neuropeptide Program 61491
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061491
- [2] Operations Pulse • Neuropeptide innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61491